(0.12%) 5 303.27 points
(0.34%) 40 004 points
(-0.07%) 16 686 points
(0.97%) $80.00
(5.73%) $2.64
(1.44%) $2 419.80
(6.36%) $31.78
(2.18%) $1 094.70
(-0.02%) $0.920
(-0.18%) $10.68
(-0.27%) $0.787
(0.19%) $91.05
5 days till quarter result
(amc 2024-05-23)
Expected move: +/- 9.92%
@ $0.850
Issued: 12 Feb 2024 @ 15:20
Return: 25.88%
Previous signal: Feb 12 - 10:52
Previous signal:
Return: -3.19 %
Live Chart Being Loaded With Signals
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis...
Stats | |
---|---|
Today's Volume | 548 024 |
Average Volume | 1.02M |
Market Cap | 101.78M |
EPS | $0 ( 2024-05-14 ) |
Next earnings date | ( $-0.0300 ) 2024-05-23 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.230 |
ATR14 | $0.00600 (0.56%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-12 | Schlessinger Sam | Buy | 38 017 | Common Stock |
2024-05-12 | Schlessinger Sam | Sell | 16 840 | Common Stock |
2024-05-12 | Schlessinger Sam | Sell | 38 017 | Restricted Stock Units |
2024-05-12 | Schwichtenberg Paul | Buy | 38 017 | Common Stock |
2024-05-12 | Schwichtenberg Paul | Sell | 16 840 | Common Stock |
INSIDER POWER |
---|
20.66 |
Last 98 transactions |
Buy: 4 439 214 | Sell: 3 257 421 |
Volume Correlation
Assertio Holdings Inc Correlation
10 Most Positive Correlations | |
---|---|
VAQC | 0.959 |
PRIM | 0.955 |
AMRB | 0.952 |
PUCK | 0.952 |
IGTA | 0.95 |
INSE | 0.95 |
PATK | 0.949 |
MKTX | 0.949 |
ULTA | 0.949 |
HOFT | 0.947 |
10 Most Negative Correlations | |
---|---|
SVAC | -0.96 |
TENX | -0.948 |
SIRI | -0.947 |
VWE | -0.943 |
GOEV | -0.94 |
LGMK | -0.94 |
JAGX | -0.939 |
MDXH | -0.934 |
LSXMK | -0.932 |
LSXMA | -0.932 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Assertio Holdings Inc Correlation - Currency/Commodity
Assertio Holdings Inc Financials
Annual | 2023 |
Revenue: | $152.07M |
Gross Profit: | $96.82M (63.67 %) |
EPS: | $-4.67 |
FY | 2023 |
Revenue: | $152.07M |
Gross Profit: | $96.82M (63.67 %) |
EPS: | $-4.67 |
FY | 2022 |
Revenue: | $156.23M |
Gross Profit: | $137.49M (88.00 %) |
EPS: | $2.33 |
FY | 2021 |
Revenue: | $111.01M |
Gross Profit: | $95.18M (85.74 %) |
EPS: | $-0.0300 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Assertio Holdings Inc
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides CAMBIA, a non-steroidal anti-inflammatory drug (NSAID) for the treatment of migraine, nausea, photophobia, and phonophobia; Zipsor, a NSAID for relief of mild to moderate acute pain; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; and Otrexup, a single-dose auto-injector containing a prescription medicine and methotrexate that is used to treat adults with severe, active rheumatoid arthritis, and children with active polyarticular juvenile idiopathic arthritis. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 1995 and is headquartered in Lake Forest, Illinois.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators